RxDoctor Payments Data

Alexander Foster, MD

Ophthalmology · Green Bay, WINPI 1992233662

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.8%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 51.9% of the total. Reporting peaked in 2019 at $1,834 and has fallen 89.1% since, to $200 in 2025.

$2,985in general payments, 2019–2025

Across 44 payments — averaging $67.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Alcon$898
  • Johnson & Johnson Surgical Vision, Inc.$234
  • Bausch & Lomb Americas Inc.$113
  • Biotissue Holdings Inc.$105
  • Rxsight Inc$29
  • plus $56 from 3 others

What the payments were for

  • Travel & lodging$1,42148%
  • Food & beverage$1,54752%
  • Entertainment$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,985 in reported general payments places this provider in the 85th percentile of 337 ophthalmology providers in Wisconsin.

See all ophthalmology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$279,719
Medicare patients
512
Services billed
1,735

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine12$17,294
LumiganBimatoprost16$8,902
RhopressaNetarsudil Mesylate18$7,309
Prednisolone Acetate85$3,048
CombiganBrimonidine Tartrate/Timolol15$2,863
Latanoprost181$2,205
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat78$1,805
ErythromycinErythromycin Base26$274
MoxifloxacinMoxifloxacin Hcl11$252
Diclofenac Sodium17$191
Timolol Maleate32$189

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Green Bay

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →